0,939  0,004  Antileukemic
0,848  0,005  Antineoplastic (colon cancer)
0,847  0,005  Antineoplastic (colorectal cancer)
0,849  0,009  Antiinflammatory
0,790  0,010  Antineoplastic (breast cancer)
0,783  0,005  Prostate cancer treatment
0,763  0,012  Antineoplastic (lung cancer)
0,714  0,028  Apoptosis agonist
0,684  0,005  Antineoplastic (glioma)
0,662  0,003  Interleukin 6 antagonist
0,635  0,005  Antineoplastic (glioblastoma multiforme)
0,621  0,014  Antineoplastic (ovarian cancer)
0,576  0,013  Antineoplastic (pancreatic cancer)
0,569  0,011  Nitric oxide antagonist
0,534  0,004  Antiviral (Influenza A)
0,536  0,024  Immunosuppressant
0,525  0,018  AR expression inhibitor
0,504  0,018  NOS2 expression inhibitor
0,526  0,041  Transcription factor NF kappa B inhibitor
0,504  0,023  Antineoplastic (melanoma)
0,481  0,006  Contraceptive
0,476  0,005  Antiviral (Influenza)
0,482  0,022  Cytostatic
0,452  0,009  Abortion inducer
0,463  0,057  TNF expression inhibitor
0,428  0,032  NOS3 expression inhibitor
0,401  0,004  Contraceptive male
0,423  0,028  Antineoplastic (multiple myeloma)
0,417  0,034  ICAM1 expression inhibitor
0,383  0,010  Lipocortins synthesis antagonist
0,454  0,081  Caspase 9 stimulant
0,399  0,036  Cytotoxic
0,418  0,059  Antipruritic, allergic
0,369  0,015  UGT2B7 substrate
0,385  0,032  Cardiovascular analeptic
0,380  0,036  Antineoplastic (non-small cell lung cancer)
0,382  0,039  Antineoplastic (cervical cancer)
0,381  0,038  Antioxidant
0,348  0,016  Antiacne
0,394  0,064  CYP3A4 substrate
0,357  0,032  Antiparasitic
0,357  0,045  UGT1A9 substrate
0,345  0,033  Antimitotic
0,348  0,040  Proliferative diseases treatment
0,318  0,020  Prostatic (benign) hyperplasia treatment
0,358  0,061  Cholesterol antagonist
0,312  0,020  Antipruritic, non-allergic
0,309  0,018  Prostate disorders treatment
0,337  0,048  UGT2B4 substrate
0,307  0,030  Antihelmintic
0,321  0,046  Tumour necrosis factor alpha release inhibitor
0,327  0,056  Sodium/bile acid cotransporter inhibitor
0,315  0,045  Antineoplastic (liver cancer)
0,297  0,031  UGT1A4 substrate
0,263  0,013  Antineoplastic antibiotic
0,293  0,043  Chemopreventive
0,304  0,055  Sensitization
0,259  0,010  Farnesoid X receptor antagonist
0,271  0,028  Neurotrophic factor enhancer
0,312  0,070  Respiratory analeptic
0,244  0,007  Arachidonic acid antagonist
0,252  0,020  UGT2B9 substrate
0,258  0,025  Lipid peroxidase inhibitor
0,239  0,007  Estrogen receptor beta antagonist
0,270  0,055  Interleukin antagonist
0,261  0,046  UDP-glucuronosyltransferase substrate
0,258  0,044  UGT1A1 substrate
0,247  0,033  Antihelmintic (Nematodes)
0,223  0,010  Estrogen antagonist
0,244  0,032  UGT1A3 substrate
0,278  0,066  GST M1-1 substrate
0,291  0,084  Antifungal
0,274  0,068  Antihypercholesterolemic
0,243  0,044  Pneumotoxic
0,282  0,083  CTGF expression inhibitor
0,282  0,086  Analeptic
0,219  0,025  UGT2B10 substrate
0,205  0,015  Growth stimulant
0,260  0,074  Antineoplastic (renal cancer)
0,258  0,074  Teratogen
0,292  0,115  GST A substrate
0,213  0,036  Interferon gamma antagonist
0,207  0,031  Antirickettsial
0,192  0,022  Microtubule formation inhibitor
0,200  0,032  Antifungal enhancer
0,229  0,060  VCAM1 expression inhibitor
0,300  0,135  Antibacterial
0,169  0,006  Estrogen receptor beta agonist
0,221  0,061  Mutagenic
0,251  0,091  CYP2C19 substrate
0,202  0,042  UGT2B15 substrate
0,168  0,009  UGT2B11 substrate
0,216  0,056  Hepatoprotectant
0,201  0,042  Toxic, respiratory center
0,177  0,019  Contraceptive female
0,243  0,088  5 Hydroxytryptamine uptake stimulant
0,166  0,017  Ca2+-transporting ATPase inhibitor
0,224  0,076  UGT1A6 substrate
0,150  0,003  Progesterone agonist
0,224  0,081  Embryotoxic
0,147  0,005  Aldosterone antagonist
0,188  0,046  Melanin inhibitor
0,228  0,089  Antipyretic
0,154  0,016  Anabolic
0,205  0,072  Anesthetic general
0,191  0,059  Tumour necrosis factor antagonist
0,261  0,134  Antineoplastic (endocrine cancer)
0,150  0,023  Androgen antagonist
0,164  0,038  Cholesterol synthesis inhibitor
0,165  0,047  Neurotrophic factor
0,190  0,074  Carcinogenic
0,161  0,046  Adenylate cyclase stimulant
0,167  0,057  Protein kinase stimulant
0,116  0,008  Antitreponemal
0,145  0,037  Alcohol dehydrogenase substrate
0,119  0,014  Estrogen agonist
0,182  0,078  P-glycoprotein inhibitor
0,165  0,060  Hair growth stimulant
0,216  0,116  Chemoprotective
0,115  0,019  Na+ K+ transporting ATPase inhibitor
0,143  0,048  Protein-tyrosine phosphatase 1B inhibitor
0,204  0,116  DNA synthesis inhibitor
0,131  0,044  Expectorant
0,088  0,003  Tubulin agonist
0,098  0,013  Antimycoplasmal
0,193  0,110  RNA-directed DNA polymerase inhibitor
0,090  0,009  Postcoital contraceptive
0,099  0,018  Anticholelithogenic
0,107  0,027  Glycine receptor antagonist
0,178  0,098  VEGF expression inhibitor
0,089  0,009  Lipocortins synthesis agonist
0,126  0,049  Mucolytic
0,096  0,023  Glycine receptor agonist
0,140  0,067  Anesthetic
0,100  0,027  Estrogen receptor alpha antagonist
0,130  0,061  DNA polymerase I inhibitor
0,080  0,012  Estrogen receptor alpha agonist
0,133  0,065  Antihemorrhagic
0,087  0,021  Androgen agonist
0,077  0,011  Anesthetic inhalation
0,070  0,007  Microtubule stabilization
0,112  0,050  GST T1-1 substrate
0,130  0,071  Tubulin antagonist
0,067  0,010  RNA-directed RNA polymerase stimulant
0,143  0,086  Protein-tyrosine phosphatase inhibitor
0,174  0,118  Antiprotozoal (Leishmania)
0,096  0,039  Opioid kappa receptor antagonist
0,115  0,061  SULT1A1 substrate
0,106  0,054  UDP-glucose 4-epimerase inhibitor
0,207  0,157  Antiallergic
0,067  0,017  Pregnane X receptor antagonist
0,089  0,040  Antibiotic
0,066  0,017  Potassium channel Kv1.3 blocker
0,055  0,009  Glucose-6-phosphate dehydrogenase inhibitor
0,106  0,063  UGT2B1 substrate
0,055  0,017  5-Alpha-reductase inhibitor
0,082  0,044  Narcotic antagonist
0,081  0,042  Cushing's syndrome treatment
0,082  0,045  Keratolytic
0,069  0,035  Aromatase inhibitor
0,065  0,033  Heme oxygenase stimulant
0,191  0,162  Gastrin inhibitor
0,121  0,092  Antimutagenic
0,210  0,182  FMO1 substrate
0,086  0,060  Ornithine decarboxylase inhibitor
0,210  0,186  CYP2C9 substrate
0,069  0,046  SULT2A1 substrate
0,042  0,018  Vanilloid 3 antagonist
0,125  0,102  Genotoxic
0,095  0,072  Glutathione S-transferase substrate
0,143  0,121  Phospholipase C inhibitor
0,093  0,072  Sulfotransferase substrate
0,055  0,035  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,026  0,007  Glucocorticoid agonist
0,086  0,067  Actinic keratosis treatment
0,023  0,005  Telomerase stimulant
0,055  0,038  Postmenopausal disorders treatment
0,156  0,140  Antialcoholic
0,020  0,004  4-Hydroxyphenylpyruvate dioxygenase inhibitor
0,038  0,023  Progesterone antagonist
0,018  0,004  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,025  0,011  Corticosteroid-like
0,052  0,038  Protein 50S ribosomal subunit inhibitor
0,089  0,075  Carcinogenic, group 2B
0,120  0,107  SULT1A3 substrate
0,034  0,021  Glucocorticoid antagonist
0,047  0,035  Mineralocorticoid receptor antagonist
0,125  0,115  Pregnane X receptor agonist
0,121  0,112  NOS3 expression enhancer
0,018  0,015  Antibiotic Anthracycline-like
0,197  0,194  Interleukin 2 agonist
0,105  0,105  Antiviral (Influenza B)
0,009  0,008  Progesterone receptor A antagonist

